Article de revue

Immunogenicity of a human rotavirus vaccine (RIX4414) after storage at 37°C for seven days

The lyophilized formulation of the human rotavirus vaccine, RIX4414 (Rotarix™), is recommended to be stored at 2°C-8°C for optimal immunogenicity. In some settings with inadequate infrastructure for vaccine storage, unforeseen circumstances may cause cold chain breakage, resulting in the vaccine to be left at ambient temperatures. This study evaluated the heat stability of lyophilized RIX4414 vaccine in terms of immunogenicity when stored at tropical room temperature (37°C) for 7 days before reconstitution.

 

Langues

  • Anglais

Année de publication

2011

Journal

Hum Vaccin.

Volume

1

Type

Article de revue

Catégories

  • Chaîne d'approvisionnement

Maladies

  • Rotavirus

Mots-clés

  • Cold room / freezer room
  • Delivery device
  • New vaccine introduction

Ajouté par: Moderator

Ajouté le: 2015-11-24 06:44:21

Consultations: 1515